Stonebridge Capital Management Buys New Amgen Stake
Stonebridge Capital Management bought 4,736 shares of Amgen for about $1.72M, while other funds also increased positions, including Anfield Capital Management and Tower View Wealth Management. Amgen’s Qtr EPS came in at $6.29 versus $5.62 expected, and the dividend payout ratio was 62.65%. Insiders sold 6,222 shares over the prior 90 days.